AZD8797

CAS: 911715-90-7 货号: A655834 分子式: C19H25N5OS2 分子量: 403.56 PubChem CID: 11965767
有货
级别和纯度: 10mM in DMSO
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
A655834-1ml
现货 Stock Image
¥879.90
请输入您要添加的产品数量

概述


AZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor; antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.

In Vitro

In a flow adhesion assay, AZD8797 antagonizes the natural ligand, fractalkine (CX3CL1), in both human whole blood (hWB) and in a B-lymphocyte cell line with IC 50 values of 300 and 6 nM respectively. AZD8797 also prevents G-protein activation in a [ 35 S]GTPγS accumulation assay. AZD8797 positively modulates the CX3CL1 response at sub-micromolar concentrations in a β-arrestin recruitment assay. In equilibrium saturation binding experiments, AZD8797 reduces the maximal binding of 125I-CX3CL1 without affecting K d. AZD8797 binds selectively with high affinity to human and rat CX3CR1 (K i of hCX3CR1, 4 nM; K i of rCX3CR1, 7 nM, respectively). The equilibrium dissociation constant, K B , demonstrates that AZD8797 is a very potent inhibitor for human CX3CR1 (10 nM). The potency is threefold lower for rat CX3CR1 (29 nM) and decreases even further at mouse CX3CR1 (54 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

AZD8797 treatment in Dark Agouti rats with myelin oligodendrocyte glycoprotein-induced EAE results in reduced paralysis, CNS pathology, and incidence of relapses. The compound is effective when starting treatment before onset, as well as after the acute phase. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal administration

Rats: AZD8797 is formulated in 30–35% (wt/wt) hydroxy-propyl-beta-cyklodextrin and administered s.c. through osmotic minipumps. Treatment is blinded to the operator. The plasma concentration of AZD8797 is analyzed twice from each rat . aladdin has not independently confirmed the accuracy of these methods. They are for reference only.

规格

规格或纯度
10mM in DMSO
英文名称
AZD8797
生化机理
AZD8797 (KAND567) 是人 CX3CR1 受体的异构非竞争性口服活性拮抗剂;可拮抗 CX3CR1 和 CXCR2,其 K i s 分别为 3.9 和 2800 nM。
储存条件
-80℃储存
运输条件
特低温运输
名称和识别符
分子类型
小分子
Isomeric SMILES
C[C@@H](C1=CC=CC=C1)SC2=NC3=C(C(=N2)N[C@H](CC(C)C)CO)SC(=N3)N
PubChem CID
分子量
403.56

高级数据

关联靶点(人)
CX3CR1 Tchem CX3C 趋化因子受体 1(CX3C chemokine receptor 1) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到1个结果

批号(Lot Number) 证书类型 货号
K2605132K2605132 分析证书 A655834
溶液计算器